Suppr超能文献

长期口服抗凝治疗患者的血浆蛋白C及维生素K依赖凝血因子水平

Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy.

作者信息

Takahashi H, Hanano M, Hayashi S, Arai Y, Yoshino N, Takakuwa E, Tatewaki W, Nagayama R, Takizawa S, Shibata A

出版信息

Tohoku J Exp Med. 1986 Aug;149(4):351-7. doi: 10.1620/tjem.149.351.

Abstract

Plasma levels of protein C (PC) and vitamin K-dependent coagulation factors (factors II, VII, IX and X) were measured in 100 specimens from patients on long-term warfarin therapy. Both activities and antigens of these coagulation factors were decreased, depending on the thrombotest values. Factor II activity/antigen ratio and factor X activity/antigen ratio were correlated well with thrombotest values, indicating that the concentration of inactive molecules (PIVKAs) relative to normal proteins increases with increasing intensity of anticoagulation. Although PC antigen (PC:Ag) was also decreased, the ratios between PC:Ag and vitamin K-dependent coagulation factor antigens remained constant, being independent of the intensity of warfarin therapy. These findings indicate that long-term oral anticoagulant therapy results in the suppression of the synthesis of both vitamin K-dependent coagulation factors and PC, but the production of the coagulant and anticoagulant proteins is well-balanced.

摘要

在100例接受长期华法林治疗患者的样本中检测了蛋白C(PC)以及维生素K依赖的凝血因子(凝血因子II、VII、IX和X)的血浆水平。这些凝血因子的活性和抗原均降低,这取决于凝血酶试验值。凝血因子II活性/抗原比值和凝血因子X活性/抗原比值与凝血酶试验值密切相关,表明相对于正常蛋白,无活性分子(PIVKAs)的浓度随着抗凝强度的增加而升高。尽管PC抗原(PC:Ag)也降低,但PC:Ag与维生素K依赖的凝血因子抗原之间的比值保持恒定,与华法林治疗强度无关。这些发现表明,长期口服抗凝治疗会抑制维生素K依赖的凝血因子和PC的合成,但促凝蛋白和抗凝蛋白的产生保持良好平衡。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验